Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial.
Abbruzzese G, Kulisevsky J, Bergmans B, Gomez-Esteban JC, Kägi G, Raw J, Stefani A, Warnecke T, Jost WH; SYNAPSES Study Investigators Group. Abbruzzese G, et al. Among authors: bergmans b. J Parkinsons Dis. 2021;11(1):187-198. doi: 10.3233/JPD-202224. J Parkinsons Dis. 2021. PMID: 33104040 Free PMC article. Clinical Trial.
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial.
Abbruzzese G, Kulisevsky J, Bergmans B, Gomez-Esteban JC, Kägi G, Raw J, Stefani A, Warnecke T, Jost WH; SYNAPSES Study Investigators Group. Abbruzzese G, et al. Among authors: bergmans b. J Parkinsons Dis. 2022;12(1):473. doi: 10.3233/JPD-219007. J Parkinsons Dis. 2022. PMID: 34275911 Free PMC article. No abstract available.
Effectiveness and safety of safinamide in routine clinical practice in a Belgian Parkinson's disease population: an open-label, levodopa add-on study.
Belgian Safinamide Study Group; Bergmans B, Bourgeois P, Cras P, Dethy S, De Klippel N, Franco G, Garraux G, Geens K, Jacquerye P, Jeanjean A, Supiot F, Van der Linden C, Krygier C. Belgian Safinamide Study Group, et al. Among authors: bergmans b. Acta Neurol Belg. 2023 Jun;123(3):939-947. doi: 10.1007/s13760-022-02100-1. Epub 2022 Oct 6. Acta Neurol Belg. 2023. PMID: 36201116 Free PMC article.
Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.
Martin S, Smolders S, Van den Haute C, Heeman B, van Veen S, Crosiers D, Beletchi I, Verstraeten A, Gossye H, Gelders G, Pals P, Hamouda NN, Engelborghs S, Martin JJ, Eggermont J, De Deyn PP, Cras P, Baekelandt V, Vangheluwe P, Van Broeckhoven C; BELNEU consortium. Martin S, et al. Acta Neuropathol. 2020 Jun;139(6):1001-1024. doi: 10.1007/s00401-020-02145-7. Epub 2020 Mar 14. Acta Neuropathol. 2020. PMID: 32172343 Free PMC article.
57 results